SUBSCRIBERS
Europe follows FDA to get nod for early stage Alzheimer's therapies
Published Thu, Mar 1, 2018 · 09:50 PM
London
EUROPEAN regulators are following in the footsteps of the US Food and Drug Administration (FDA) with plans to help pharmaceutical companies win approval for novel Alzheimer's drugs that treat the earliest stages of the memory-robbing disease.
The European Medicines Agency said on Wednesday that its new guidance would encourage the testing of new medicines even before symptoms appeared, as well as the potential use of biomark…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Japan’s 7-Eleven convenience chain targets aggressive global growth
Bubble tea maker Chabaidao slumps 10% in Hong Kong’s biggest 2024 debut
Parental fury after stem cell bank ruins thousands of samples in Singapore
China’s bubble tea boom creates a half-dozen billionaires
US sues to block Coach owner’s US$8.5 billion buyout of Versace parent
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO